These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 8605006)
21. R-form LPS, the master key to the activation ofTLR4/MD-2-positive cells. Huber M; Kalis C; Keck S; Jiang Z; Georgel P; Du X; Shamel L; Sovath S; Mudd S; Beutler B; Galanos C; Freudenberg MA Eur J Immunol; 2006 Mar; 36(3):701-11. PubMed ID: 16506285 [TBL] [Abstract][Full Text] [Related]
22. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis. Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399 [TBL] [Abstract][Full Text] [Related]
23. Neutralizing and cross-reactive antibodies against enterobacterial lipopolysaccharide. Müller-Loennies S; Brade L; Brade H Int J Med Microbiol; 2007 Sep; 297(5):321-40. PubMed ID: 17544324 [TBL] [Abstract][Full Text] [Related]
24. Characterization and serological classification of O-specific polysaccharide of Proteus mirabilisTG 276-90 from Proteus serogroup O34. Kołodziejska K; Siwińska M; Zych K; Rózalski A; Sidorczyk Z Arch Immunol Ther Exp (Warsz); 2006; 54(3):223-6. PubMed ID: 16736109 [TBL] [Abstract][Full Text] [Related]
25. Characterisation of protein co-extracted together with LPS in Escherichia coli, Salmonella minnesota and Yersinia enterocolitica. Strittmatter W; Galanos C Microb Pathog; 1987 Jan; 2(1):29-36. PubMed ID: 3333795 [TBL] [Abstract][Full Text] [Related]
27. Structure and serological characterization of an Nepsilon-[(R)-1-carboxyethyl]-L-lysine-containing O-chain of the lipopolysaccharide of Proteus mirabilis O13. Swierzko AS; Cedzyński M; Ziółkowski A; Senchenkova SN; Perepelov AV; Knirel YA; Kaca W Arch Immunol Ther Exp (Warsz); 2001; 49(2):163-9. PubMed ID: 11348021 [TBL] [Abstract][Full Text] [Related]
28. Classification of Proteus mirabilis TG 115 and CCUG 10701 into the Proteus O23 serogroup based on chemical and serological studies of O-polysaccharides. Zabłotni A; Perepelov AV; Kołodziejska K; Zych K; Knirel YA; Sidorczyk Z Arch Immunol Ther Exp (Warsz); 2006; 54(6):411-7. PubMed ID: 17122881 [TBL] [Abstract][Full Text] [Related]
29. [Tests for studying invasive properties of selected Proteus mirabilis strains]. Bartodziejska B; Wykrota M; Rózalski A; Kaca W Med Dosw Mikrobiol; 2001; 53(3):277-82. PubMed ID: 11785185 [TBL] [Abstract][Full Text] [Related]
30. Mechanisms of action of rabbit CAP18 on monolayers and liposomes made from endotoxins or phospholipids. Gutsmann T; Fix M; Larrick JW; Wiese A J Membr Biol; 2000 Aug; 176(3):223-36. PubMed ID: 10931974 [TBL] [Abstract][Full Text] [Related]
31. [Comparative characterization of the physico-chemical properties of lipopolysaccharides of Yersinia pestis and R-mutants of enterobacteria]. Gremiakova TA; Fomchenkov VM; Fursova NK; Volkovoĭ KI Mikrobiologiia; 1996; 65(6):763-7. PubMed ID: 9102553 [TBL] [Abstract][Full Text] [Related]
32. Structure of the O-polysaccharide of Proteus mirabilis CCUG 10705 (OF) containing an amide of D-galacturonic acid with L-alanine. Perepelov AV; Zabłotni A; Shashkov AS; Knirel YA; Sidorczyk Z Carbohydr Res; 2006 Aug; 341(11):1969-74. PubMed ID: 16697996 [TBL] [Abstract][Full Text] [Related]
33. Structure of the O-polysaccharide of Proteus mirabilis O19 and reclassification of certain Proteus strains that were formerly classified in serogroup O19. Perepelov AV; Rózalski A; Bartodziejska B; Senchenkova SN; Knirel YA Arch Immunol Ther Exp (Warsz); 2004; 52(3):188-96. PubMed ID: 15247885 [TBL] [Abstract][Full Text] [Related]
34. Elution of lipopolysaccharides from polyacrylamide gels. Hardy E; Pupo E; Santana H; Guerra M; Castellanos-Serra LR Anal Biochem; 1998 May; 259(1):162-5. PubMed ID: 9606157 [TBL] [Abstract][Full Text] [Related]
36. Stimulatory effects of endotoxin on the platelet secretory process. Saluk-Juszczak J; Wachowicz B; Kaca W Microbios; 1999; 99(392):45-53. PubMed ID: 10624010 [TBL] [Abstract][Full Text] [Related]
37. Laser interferometric and cultivation methods for measurement of colistin/ampicilin and saponin interactions with smooth and rough of Proteus mirabilis lipopolysaccharides and cells. Arabski M; Wasik S; Dworecki K; Kaca W J Microbiol Methods; 2009 May; 77(2):178-83. PubMed ID: 19318050 [TBL] [Abstract][Full Text] [Related]
38. Potential integration sites of the Salmonella genomic island 1 in Proteus mirabilis and other bacteria. Doublet B; Golding GR; Mulvey MR; Cloeckaert A J Antimicrob Chemother; 2007 Apr; 59(4):801-3. PubMed ID: 17293370 [No Abstract] [Full Text] [Related]
39. Characterization of Proteus mirabilis Lipopolysaccharide Samples by Infrared Spectroscopy and Serological Methods. Durlik K; Czerwonka G; Żarnowiec P; Kaca W Methods Mol Biol; 2019; 2021():217-230. PubMed ID: 31309508 [TBL] [Abstract][Full Text] [Related]
40. Vibrio fischeri lipopolysaccharide induces developmental apoptosis, but not complete morphogenesis, of the Euprymna scolopes symbiotic light organ. Foster JS; Apicella MA; McFall-Ngai MJ Dev Biol; 2000 Oct; 226(2):242-54. PubMed ID: 11023684 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]